Article title: Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®
Authors: Danila Seidel, Arne Meißner, Michaela Lackner , Ellen Piepenbrock, Jon Salmanton-García, Melanie Stecher, Sibylle Mellinghoff, Axel Hamprecht, Luisa Durán Graeff, Philipp Köhler, Matthew P. Cheng, Julie Denis, Isabelle Chedotal, Jagdish Chander, Diana Lynn Pakstis, Ibai Los-Arcos, Monica Slavin, Maria Teresa Montagna, Giuseppina Caggiano, Mihai Mares, Janina Trauth, Ute Aurbach, Maria J. G. T. Vehreschild, Jörg Janne Vehreschild, Rafael F. Duarte, Raoul Herbrecht, Hilmar Wisplinghoff and Oliver A. Cornely
Collaborators: Björn Bachmann, Kersten Borchert, Alexander Burchardt, Arunaloke Chakrabarti, Maximilian Christopeit, Naima Fasih, Khosro Hekmat, Belén Hernández Rupérez, Björn Kemmerling, Johanna Kessel, Anupma Jyoti Kindo, Nikolay Klimko, Robert Krause, Cornelia Lass-Flörl, Eric Levesque, Shawn Lockhart, Jörg Steinmann, Alessandro Maritati, Birgid Markiefka, Maria Teresa Martín Gómez, Jacques Meis, Jarmo Oksi, Livio Pagano, Antonio Ramos Martinez, Frederike Reischies, Pere Soler Palacin and Edith Vermeulen
Journal: Clinical Reviews in Microbiology
DOI: http://dx.doi.org/10.1080/1040841X.2018.1514366
In the above article the list of authors was incorrectly published. The list of contributors has now been separated into ‘Authors’ and ‘Collaborators’ as given above.
The conflict of interest statement was also missing, this is now included in the published version and is also given below.
Disclosure statement
DS, JD, LDG, UA, GC, MPC, JC, RD, ILA, MM, AM, SM, MTM, DLP, EP, JSG, MSt, JT, HW having nothing to disclose.
AH reports personal fees from Astellas, personal fees from Gilead, personal fees from MSD, outside the submitted work.
RH reports personal fees from Astellas, personal fees from Basilea, personal fees from Gilead, personal fees from MSD, grants and personal fees from Pfizer, outside the submitted work.
PK reports personal fees from Cologne Cluster of Excellence - Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, non-financial support from Merck/MSD, non-financial support from MedImmune, other from Astellas, outside the submitted work.
ML reports grants and personal fees from Astellas Pharma, grants from MSD, personal fees from Forest Pharma, outside the submitted work.
MSl reports grants from Merck, personal fees from Gilead, personal fees from Merck, outside the submitted work.
JJV reports grants and personal fees from Merck/MSD, grants and personal fees from Astellas Pharma, grants and personal fees from Basilea, grants and personal fees from Deutsches Zentrum für Infektionsforschung, personal fees from Akademie für Infektionsmedizin, grants from Bundesministerium für Bildung und Forschung, personal fees from Uniklinik Freiburg/Kongress und Kommunikation, personal fees from Universität Manchester, personal fees from Deutsche Gesellschaft für Infektiologie, personal fees from Deutsche Gesellschaft für Innere Medizin, personal fees from Ärztekammer Nordrhein, personal fees from Uniklinik Aachen, personal fees from Back Bay Strategies, outside the submitted work.
MV reports personal fees from Merck/MSD, grants and personal fees from Astellas, grants and personal fees from Gilead Sciences, grants from 3 M, personal fees from Berlin Chemie, grants and personal fees from DaVolterra, personal fees from Pfizer, personal fees from Organobalance, outside the submitted work.
OAC reports research grants from Actelion, Amplyx, Arsanis, Astellas, AstraZeneca, Basilea, Bayer, Cidara, F2G, Gilead, GSK, Leeds University, Matinas, Medicines Company, MedPace, Melinta, Merck/MSD, Miltenyi, Pfizer, Rempex, Roche, Sanofi Pasteur, Scynexis, Seres, is a consultant to Allecra Therapeutics, Amplyx, Actelion, Astellas, Basilea, Cidara, Da Volterra, F2G, Gilead, IQVIA, Janssen, Matinas, Menarini, Merck/MSD, Paratek, PSI, Scynexis, Seres, Summit, Tetraphase, Vical, and received lecture honoraria from Astellas, Basilea, Gilead, Merck/MSD and Pfizer, outside the submitted work.